$3.30
-0.06-1.90%
Pre-Market: Mar 24, 5:11 PM EDT
Comments
Loading...
Scinai Immunotherapeutics Analyst Ratings and Price Targets | NASDAQ:SCNI | Benzinga
Scinai Immunotherapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Scinai Immunotherapeutics Corp from these most-recent analyst ratings.
Analyst Ratings for Scinai Immunotherapeutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Scinai Immunotherapeutics (SCNI) stock?
There is no price target for Scinai Immunotherapeutics
What is the most recent analyst rating for Scinai Immunotherapeutics (SCNI)?
There is no analyst for Scinai Immunotherapeutics
When was the last upgrade for Scinai Immunotherapeutics (SCNI)?
There is no last upgrade for Scinai Immunotherapeutics
When was the last downgrade for Scinai Immunotherapeutics (SCNI)?
There is no last downgrade for Scinai Immunotherapeutics.
When is the next analyst rating going to be posted or updated for Scinai Immunotherapeutics (SCNI)?
There is no next analyst rating for Scinai Immunotherapeutics.
Is the Analyst Rating Scinai Immunotherapeutics (SCNI) correct?
There is no next analyst rating for Scinai Immunotherapeutics.
Browse analyst ratings and price targets on all stocks.